Clinical trial
Efficacy and Safety of Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection - A Pilot Study
NCT03603327 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection - A Pilot Study
- Lead sponsor
- Soroka University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 25, 2018
- Completion date
- December 31, 2020
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.